Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results.

Okubo, Yukari; Umezawa, Yoshinori; Sakurai, Shinya; Hoshii, Naoki; Nakagawa, Hidemi.

Afiliação

Okubo Y; Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
Umezawa Y; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
Sakurai S; UCB Pharma, 8 Chome-17-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. Shinya.Sakurai@ucb.com.
Hoshii N; UCB Pharma, 8 Chome-17-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Nakagawa H; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.

Dermatol Ther (Heidelb) ; 12(6): 1397-1415, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35622315